AdaptHealth Corp. Announces Appointment of Russell Schuster as Chief Commercial Officer
December 03 2024 - 8:00AM
Business Wire
AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the
“Company”), a national leader in providing patient-centered,
healthcare-at-home solutions including home medical equipment,
medical supplies, and related services, announced today that
Russell Schuster has been appointed Chief Commercial Officer,
effective December 2nd, 2024.
In his new role, Mr. Schuster will oversee commercial strategy
and revenue generation for the Company. He is a seasoned executive
with more than 25 years of experience and a proven track record of
growing large businesses. Most recently, Mr. Schuster served as
President of Cardinal Health Canada, where he delivered meaningful
performance improvement. Over eight years at Cardinal Health, he
held positions of increasing responsibility in Corporate
Development, Business Development, and Strategy.
Prior to joining Cardinal Health, Mr. Schuster served in
progressive roles within Investment Banking and M&A at Lehman
Brothers, Barclays Capital, and Republic Services. Mr. Schuster
began his career as a CPA and Consultant with Ernst &
Young.
Suzanne Foster, Chief Executive Officer of AdaptHealth, said,
"We are thrilled to welcome Russ to the AdaptHealth team. Russ’s
experience leading large-scale growth initiatives fills an
important need for the Company. His appointment as Chief Commercial
Officer will be critical to the execution of our strategic plan and
driving top line growth, while ensuring our commitment to
exceptional patient care."
About AdaptHealth Corp.
AdaptHealth is a national leader in providing patient-centered,
healthcare-at-home solutions including home medical equipment
(HME), medical supplies, and related services. The Company provides
a full suite of medical products and solutions designed to help
patients manage chronic conditions in the home, adapt to challenges
in their activities of daily living, and thrive. Product and
service offerings include (i) sleep therapy equipment, supplies,
and related services (including CPAP and bi PAP services) to
individuals suffering from obstructive sleep apnea, (ii) medical
devices and supplies to patients for the treatment of diabetes
(including continuous glucose monitors and insulin pumps), (iii)
HME to patients discharged from acute care and other facilities,
(iv) oxygen and related chronic therapy services in the home, and
(v) other HME devices and supplies on behalf of chronically ill
patients with wound care, urological, incontinence, ostomy and
nutritional supply needs. The Company is proud to partner with an
extensive and highly diversified network of referral sources,
including acute care hospitals, sleep labs, pulmonologists, skilled
nursing facilities, and clinics. AdaptHealth services beneficiaries
of Medicare, Medicaid, and commercial insurance payors, reaching
approximately 4.2 million patients annually in all 50 states
through its network of approximately 670 locations in 47
states.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20241203265225/en/
AdaptHealth Corp. Jason Clemens, CFA Chief Financial
Officer IR@adapthealth.com
Luke Montgomery, CFA SVP, Investor Relations
luke.montgomery@adapthealth.com
AdaptHealth (NASDAQ:AHCO)
Historical Stock Chart
From Nov 2024 to Dec 2024
AdaptHealth (NASDAQ:AHCO)
Historical Stock Chart
From Dec 2023 to Dec 2024